Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1987 2
1988 1
1989 1
1990 1
1991 1
1992 2
1993 1
1995 1
1998 2
1999 1
2000 2
2001 3
2002 3
2003 1
2004 4
2005 6
2006 2
2008 4
2009 4
2010 6
2011 5
2012 3
2013 4
2014 7
2015 7
2016 10
2017 9
2018 10
2019 12
2020 7
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32503896

104 results
Results by year
Filters applied: . Clear all
Page 1
Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis.
De Leo E, Elmonem MA, Berlingerio SP, Berquez M, Festa BP, Raso R, Bellomo F, Starborg T, Janssen MJ, Abbaszadeh Z, Cairoli S, Goffredo BM, Masereeuw R, Devuyst O, Lowe M, Levtchenko E, Luciani A, Emma F, Rega LR. De Leo E, et al. J Am Soc Nephrol. 2020 Jul;31(7):1522-1537. doi: 10.1681/ASN.2019090956. Epub 2020 Jun 5. J Am Soc Nephrol. 2020. PMID: 32503896
Protection of Cystinotic Mice by Kidney-Specific Megalin Ablation Supports an Endocytosis-Based Mechanism for Nephropathic Cystinosis Progression.
Janssens V, Gaide Chevronnay HP, Marie S, Vincent MF, Van Der Smissen P, Nevo N, Vainio S, Nielsen R, Christensen EI, Jouret F, Antignac C, Pierreux CE, Courtoy PJ. Janssens V, et al. J Am Soc Nephrol. 2019 Nov;30(11):2177-2190. doi: 10.1681/ASN.2019040371. Epub 2019 Sep 23. J Am Soc Nephrol. 2019. PMID: 31548351
Activation of the transcription factor EB rescues lysosomal abnormalities in cystinotic kidney cells.
Rega LR, Polishchuk E, Montefusco S, Napolitano G, Tozzi G, Zhang J, Bellomo F, Taranta A, Pastore A, Polishchuk R, Piemonte F, Medina DL, Catz SD, Ballabio A, Emma F. Rega LR, et al. Kidney Int. 2016 Apr;89(4):862-73. doi: 10.1016/j.kint.2015.12.045. Kidney Int. 2016. PMID: 26994576 Free article.
Chaperone-Mediated Autophagy Upregulation Rescues Megalin Expression and Localization in Cystinotic Proximal Tubule Cells.
Zhang J, He J, Johnson JL, Rahman F, Gavathiotis E, Cuervo AM, Catz SD. Zhang J, et al. Front Endocrinol (Lausanne). 2019 Feb 1;10:21. doi: 10.3389/fendo.2019.00021. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30774622 Free PMC article.
Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.
Hollywood JA, Przepiorski A, D'Souza RF, Sreebhavan S, Wolvetang EJ, Harrison PT, Davidson AJ, Holm TM. Hollywood JA, et al. J Am Soc Nephrol. 2020 May;31(5):962-982. doi: 10.1681/ASN.2019070712. Epub 2020 Mar 20. J Am Soc Nephrol. 2020. PMID: 32198276
Altered mTOR signalling in nephropathic cystinosis.
Ivanova EA, van den Heuvel LP, Elmonem MA, De Smedt H, Missiaen L, Pastore A, Mekahli D, Bultynck G, Levtchenko EN. Ivanova EA, et al. J Inherit Metab Dis. 2016 May;39(3):457-464. doi: 10.1007/s10545-016-9919-z. Epub 2016 Feb 24. J Inherit Metab Dis. 2016. PMID: 26909499
Cystinosin is a Component of the Vacuolar H+-ATPase-Ragulator-Rag Complex Controlling Mammalian Target of Rapamycin Complex 1 Signaling.
Andrzejewska Z, Nevo N, Thomas L, Chhuon C, Bailleux A, Chauvet V, Courtoy PJ, Chol M, Guerrera IC, Antignac C. Andrzejewska Z, et al. J Am Soc Nephrol. 2016 Jun;27(6):1678-88. doi: 10.1681/ASN.2014090937. Epub 2015 Oct 8. J Am Soc Nephrol. 2016. PMID: 26449607 Free PMC article.
Effects of long-term cysteamine treatment in patients with cystinosis.
Ariceta G, Giordano V, Santos F. Ariceta G, et al. Pediatr Nephrol. 2019 Apr;34(4):571-578. doi: 10.1007/s00467-017-3856-4. Epub 2017 Dec 19. Pediatr Nephrol. 2019. PMID: 29260317 Free PMC article. Review.
104 results
Jump to page
Feedback